Paul J Clancy Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

AGIO Quotes by TradingView

Paul J Clancy is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,549 shares of AGIO, which is worth approximately $385,539. The most recent transaction as insider was on May 20, 2022, when has been sold 1,585 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.55K
0% 3M change
0% 12M change
Total Value Held $385,539

Paul J Clancy Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2022
BUY
Exercise of conversion of derivative security
-
1,585 Added 19.49%
6,549 Common Stock
May 28 2021
BUY
Exercise of conversion of derivative security
-
1,686 Added 25.35%
4,964 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
Director
EXAS
EXACT SCIENCES CORP Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
PJC

Paul J Clancy

Director
Wilmington, DE

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGIO